The Risk of Tuberculosis Related to Tumour Necrosis Factor Antagonist Therapies: A TBNET Consensus Statement

European Respiratory Journal - United Kingdom
doi 10.1183/09031936.00028510
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

LTBI: Latent Tuberculosis Infection or Lasting Immune Responses to M. Tuberculosis? A TBNET Consensus Statement

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2009English

Pulmonary Granulomas After Tumour Necrosis Factor Alpha Antagonist Therapy

Thorax
PulmonaryRespiratory Medicine
2003English

Reactivation of M. Tuberculosis Infection in Trans-Membrane Tumour Necrosis Factor Mice

PLoS ONE
Multidisciplinary
2011English

The Use of the Tumour Necrosis Factor Antagonist Infliximab in Heart Transplant Recipients: Two Case Reports

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2007English

E0154 Expression of Tumour Necrosis Factor- Converting Enzyme and Tumour Necrosis Factor- In Rats With Alcoholic Cardiomyopathy

Heart
Cardiovascular MedicineCardiology
2010English

Giant Cell Myocarditis in a Patient With Crohn's Disease, Treated With Etanercept – A Tumour Necrosis Factor-Alpha Antagonist

Canadian Journal of Gastroenterology
2001English

Crystallization and Preliminary X-Ray Analysis of the Tumour Necrosis Factor Α–tumour Necrosis Factor Receptor Type 2 Complex

Acta Crystallographica Section F Structural Biology and Crystallization Communications
2009English

Systemic Cytotoxic and Biological Therapies of Colorectal Liver Metastases: Expert Consensus Statement

HPB
HepatologyGastroenterology
2013English

Circulating Tumour Necrosis Factor Alpha and Soluble Tumour Necrosis Factor Receptors in Patients With Different Patterns of Rheumatoid Synovitis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy